title: Liposomal nystatin (L-NYS) in therapy of pulmonary aspergillosis refractory to conventional amphotericin B in cancer patients.
authors.forename: Y
authors.initials: Y
authors.lastname: Krupova
authors.forename: M
authors.initials: M
authors.lastname: Mistrik
authors.forename: E
authors.initials: E
authors.lastname: Bojtarova
authors.forename: D
authors.initials: D
authors.lastname: Sejnova
authors.forename: I
authors.initials: I
authors.lastname: Ilavska
authors.forename: V
authors.initials: V
authors.lastname: Krcmery
mesh_terms: D000293:Adolescent; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001228:Aspergillosis / Q000188:drug therapy*; D002648:Child; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008081:Liposomes; D008172:Lung Diseases, Fungal / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D009761:Nystatin / Q000008:administration & dosage* / Q000009:adverse effects; D017211:Treatment Failure; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D008081:Liposomes; D009761:Nystatin; D000666:Amphotericin B; D015725:Fluconazole